Diabetes drug Tzield yields Rockville’s MacroGenics a big check for royalty stake – Washington Business Journal

The deal stands to drive hundreds of millions more to the local company over time.

Image: Scott Koenig is president and CEO of Rockville’s MacroGenics. JOANNE S. LAWTON